News >

European Commission Approves Oral Rolapitant for CINV

Jason Harris
Published: Wednesday, Apr 26, 2017

Florian Scotté, MD, PhD

Florian Scotté, MD, PhD

The European Commission has approved oral rolapitant tablets (Varuby) for the treatment of delayed chemotherapy-induced nausea and vomiting (CINV) in adults.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 22nd Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas and MyelomaMay 30, 20192.0
Online Medical Crossfire®: 5th Annual Miami Lung Cancer ConferenceMay 30, 20196.5
Publication Bottom Border
Border Publication
x